Almost 45,000 people are diagnosed with cancer in Ireland every year, including lung, bowel, breast, prostate and skin cancer. Cases of cancer are expected to double in Ireland by 2040.
Collaboration between cancer researchers, educators, clinicians and patients is key to ensuring that cancers are diagnosed early, that treatments improve and that survival rates increase.
The Beaumont RCSI Cancer Centre is an internationally accredited Centre that strives to integrate world-class cancer research and clinical education into the treatment of patients across all types of cancer.
The Centre is an innovative collaboration between clinicians and scientists at Beaumont Hospital, RCSI University of Medicine and Health Sciences and St Luke’s Radiation Oncology Network.
Through its collaborative approach, the Centre aims to further develop the clinical treatment pathways for patients to improve their experience and outcomes and also extend into local communities to support health and well-being programmes aimed at prevention.
The Centre is aligned with the strategic priorities of the National Cancer Strategy (2017-2026), EU Cancer Mission and Europe’s Beating Cancer Plan.
In May 2022, it became the second only cancer centre in the country to be accredited by the OECI, Europe’s accreditation body for cancer research, education and clinical care. The Centre was accredited in recognition of its commitment to delivering high standards of quality care to patients with cancer and to accelerating developments in cancer research.
Cancer research at the Centre focuses on a wide variety of strategies to identify new ways to improve outcomes for cancer patients through prevention, diagnosis and therapy. It is involved in large-scale collaborative cancer research programmes and clinical trials involving partners from industry, academia and clinical organisations. The role of RCSI is to enable in the combination of scientific research with patient treatment to assist the Centre in achieving its goals.
The Beaumont RCSI Cancer Centre held its inaugural conference in September 2022, entitled ‘The vision for comprehensive cancer care in Ireland’. The conference celebrated the OECI accreditation, and brought together international experts in cancer care – including Prof Leonie Young, Scientific Director of the Centre, Professor Alastair Thompson, Breast Cancer Surgeon at Baylor College of Medicine and Dr Jean-Benoît Burrion, Chair of the OECI Accreditation and Designation Programme – to share their vision for cancer care in Ireland.
RCSI is committed to achieving a better and more sustainable future through the UN Sustainable Development Goals.